These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 20140192)

  • 1. Immunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane.
    Hammonds J; Wang JJ; Yi H; Spearman P
    PLoS Pathog; 2010 Feb; 6(2):e1000749. PubMed ID: 20140192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-Dimensional Structural Characterization of HIV-1 Tethered to Human Cells.
    Strauss JD; Hammonds JE; Yi H; Ding L; Spearman P; Wright ER
    J Virol; 2016 Feb; 90(3):1507-21. PubMed ID: 26582000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of the Cytoplasmic Determinants of Vpu to the Expansion of Virus-Containing Compartments in HIV-1-Infected Macrophages.
    Leymarie O; Lepont L; Versapuech M; Judith D; Abelanet S; Janvier K; Berlioz-Torrent C
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of HIV-1 Vpu leads to loss of the viral restriction factor CD317/Tetherin from lipid rafts and its enhanced lysosomal degradation.
    Rollason R; Dunstan K; Billcliff PG; Bishop P; Gleeson P; Wise H; Digard P; Banting G
    PLoS One; 2013; 8(9):e75680. PubMed ID: 24086611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetherin inhibits HIV-1 release by directly tethering virions to cells.
    Perez-Caballero D; Zang T; Ebrahimi A; McNatt MW; Gregory DA; Johnson MC; Bieniasz PD
    Cell; 2009 Oct; 139(3):499-511. PubMed ID: 19879838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetherin restricts productive HIV-1 cell-to-cell transmission.
    Casartelli N; Sourisseau M; Feldmann J; Guivel-Benhassine F; Mallet A; Marcelin AG; Guatelli J; Schwartz O
    PLoS Pathog; 2010 Jun; 6(6):e1000955. PubMed ID: 20585562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles.
    Fitzpatrick K; Skasko M; Deerinck TJ; Crum J; Ellisman MH; Guatelli J
    PLoS Pathog; 2010 Mar; 6(3):e1000701. PubMed ID: 20221443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CAML does not modulate tetherin-mediated restriction of HIV-1 particle release.
    Ali MS; Hammonds J; Ding L; Spearman P
    PLoS One; 2010 Feb; 5(2):e9005. PubMed ID: 20126395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin.
    Pardieu C; Vigan R; Wilson SJ; Calvi A; Zang T; Bieniasz P; Kellam P; Towers GJ; Neil SJ
    PLoS Pathog; 2010 Apr; 6(4):e1000843. PubMed ID: 20419159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes.
    Iwabu Y; Fujita H; Kinomoto M; Kaneko K; Ishizaka Y; Tanaka Y; Sata T; Tokunaga K
    J Biol Chem; 2009 Dec; 284(50):35060-72. PubMed ID: 19837671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetherin is as tetherin does.
    Hammonds J; Spearman P
    Cell; 2009 Oct; 139(3):456-7. PubMed ID: 19879831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation.
    Mangeat B; Gers-Huber G; Lehmann M; Zufferey M; Luban J; Piguet V
    PLoS Pathog; 2009 Sep; 5(9):e1000574. PubMed ID: 19730691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCA2/Rabring7 promotes tetherin-dependent HIV-1 restriction.
    Miyakawa K; Ryo A; Murakami T; Ohba K; Yamaoka S; Fukuda M; Guatelli J; Yamamoto N
    PLoS Pathog; 2009 Dec; 5(12):e1000700. PubMed ID: 20019814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative multicolor super-resolution microscopy reveals tetherin HIV-1 interaction.
    Lehmann M; Rocha S; Mangeat B; Blanchet F; Uji-I H; Hofkens J; Piguet V
    PLoS Pathog; 2011 Dec; 7(12):e1002456. PubMed ID: 22194693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Vpu Antagonizes CD317/Tetherin by Adaptor Protein-1-Mediated Exclusion from Virus Assembly Sites.
    Pujol FM; Laketa V; Schmidt F; Mukenhirn M; Müller B; Boulant S; Grimm D; Keppler OT; Fackler OT
    J Virol; 2016 Aug; 90(15):6709-6723. PubMed ID: 27170757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation.
    Morrison JH; Guevara RB; Marcano AC; Saenz DT; Fadel HJ; Rogstad DK; Poeschla EM
    J Virol; 2014 Mar; 88(6):3255-72. PubMed ID: 24390322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperation of the Ebola Virus Proteins VP40 and GP
    Rizk MG; Basler CF; Guatelli J
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.
    Neil SJ; Zang T; Bieniasz PD
    Nature; 2008 Jan; 451(7177):425-30. PubMed ID: 18200009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion.
    Yan R; Zhao X; Cai D; Liu Y; Block TM; Guo JT; Guo H
    J Virol; 2015 Sep; 89(18):9200-12. PubMed ID: 26109732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration.
    Gupta RK; Mlcochova P; Pelchen-Matthews A; Petit SJ; Mattiuzzo G; Pillay D; Takeuchi Y; Marsh M; Towers GJ
    Proc Natl Acad Sci U S A; 2009 Dec; 106(49):20889-94. PubMed ID: 19864625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.